Selected research
Industry Research
Phage Display Service Industry Research Report 2026
Market perspective
The global Phage Display Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Phage Display Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Phage Display Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Phage Display Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Phage Display Service include Creative Biogene, Creative Biolabs, ProteoGenix, CUSABIO, Diaclone, Biomolecular Discovery Services, Charles River, GenScript and Synbio Technologies, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Phage Display Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Phage Display Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Phage Display Service Market by Company
Creative Biogene
Creative Biolabs
ProteoGenix
CUSABIO
Diaclone
Biomolecular Discovery Services
Charles River
GenScript
Synbio Technologies
Creative Peptides
ProImmune
Absolute Antibody
Iontas
LakePharma
KMD Bioscience
NeoClone
Pepscan
Abzena
ChemPartner
Creative Proteomics
Yntoab
Diane biological
Biosynth
Zoonbio Biotechnology
Abiocenter
Phage Display Service Segment by Type
cDNA Library
Antibody Library
Protein Library
Random Peptide Library
Phage Display Service Segment by Application
Immunotherapy
Drug Discovery
Functional Genomics
Others
Phage Display Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phage Display Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Phage Display Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phage Display Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Phage Display Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- cDNA Library
- Antibody Library
- Protein Library
- Random Peptide Library
Applications
- Immunotherapy
- Drug Discovery
- Functional Genomics
- Others
Companies covered
- Creative Biogene
- Creative Biolabs
- ProteoGenix
- CUSABIO
- Diaclone
- Biomolecular Discovery Services
- Charles River
- GenScript
- Synbio Technologies
- Creative Peptides
- ProImmune
- Absolute Antibody
- Iontas
- LakePharma
- KMD Bioscience
- NeoClone
- Pepscan
- Abzena
- ChemPartner
- Creative Proteomics
- Yntoab
- Diane biological
- Biosynth
- Zoonbio Biotechnology
- Abiocenter
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Phage Display Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 cDNA Library
- 2.2.3 Antibody Library
- 2.2.4 Protein Library
- 2.2.5 Random Peptide Library
- 2.3 Phage Display Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Immunotherapy
- 2.3.3 Drug Discovery
- 2.3.4 Functional Genomics
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Phage Display Service Breakdown Data by Type
- 3.1 Global Phage Display Service Historic Market Size by Type (2021-2026)
- 3.2 Global Phage Display Service Forecasted Market Size by Type (2027-2032)
4 Phage Display Service Breakdown Data by Application
- 4.1 Global Phage Display Service Historic Market Size by Application (2021-2026)
- 4.2 Global Phage Display Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Phage Display Service Market Perspective (2021-2032)
- 5.2 Global Phage Display Service Growth Trends by Region
- 5.2.1 Global Phage Display Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Phage Display Service Historic Market Size by Region (2021-2026)
- 5.2.3 Phage Display Service Forecasted Market Size by Region (2027-2032)
- 5.3 Phage Display Service Market Dynamics
- 5.3.1 Phage Display Service Industry Trends
- 5.3.2 Phage Display Service Market Drivers
- 5.3.3 Phage Display Service Market Challenges
- 5.3.4 Phage Display Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Phage Display Service Players by Revenue
- 6.1.1 Global Top Phage Display Service Players by Revenue (2021-2026)
- 6.1.2 Global Phage Display Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Phage Display Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Phage Display Service Head Office and Area Served
- 6.4 Global Phage Display Service Players, Product Type & Application
- 6.5 Global Phage Display Service Manufacturers Established Date
- 6.6 Global Phage Display Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Phage Display Service Market Size (2021-2032)
- 7.2 North America Phage Display Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Phage Display Service Market Size by Country (2021-2026)
- 7.4 North America Phage Display Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Phage Display Service Market Size (2021-2032)
- 8.2 Europe Phage Display Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Phage Display Service Market Size by Country (2021-2026)
- 8.4 Europe Phage Display Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Phage Display Service Market Size (2021-2032)
- 9.2 Asia-Pacific Phage Display Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Phage Display Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Phage Display Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Phage Display Service Market Size (2021-2032)
- 10.2 South America Phage Display Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Phage Display Service Market Size by Country (2021-2026)
- 10.4 South America Phage Display Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Phage Display Service Market Size (2021-2032)
- 11.2 Middle East & Africa Phage Display Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Phage Display Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Phage Display Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Creative Biogene
- 12.1.1 Creative Biogene Company Information
- 12.1.2 Creative Biogene Business Overview
- 12.1.3 Creative Biogene Revenue in Phage Display Service Business (2021-2026)
- 12.1.4 Creative Biogene Phage Display Service Product Portfolio
- 12.1.5 Creative Biogene Recent Developments
- 12.2 Creative Biolabs
- 12.2.1 Creative Biolabs Company Information
- 12.2.2 Creative Biolabs Business Overview
- 12.2.3 Creative Biolabs Revenue in Phage Display Service Business (2021-2026)
- 12.2.4 Creative Biolabs Phage Display Service Product Portfolio
- 12.2.5 Creative Biolabs Recent Developments
- 12.3 ProteoGenix
- 12.3.1 ProteoGenix Company Information
- 12.3.2 ProteoGenix Business Overview
- 12.3.3 ProteoGenix Revenue in Phage Display Service Business (2021-2026)
- 12.3.4 ProteoGenix Phage Display Service Product Portfolio
- 12.3.5 ProteoGenix Recent Developments
- 12.4 CUSABIO
- 12.4.1 CUSABIO Company Information
- 12.4.2 CUSABIO Business Overview
- 12.4.3 CUSABIO Revenue in Phage Display Service Business (2021-2026)
- 12.4.4 CUSABIO Phage Display Service Product Portfolio
- 12.4.5 CUSABIO Recent Developments
- 12.5 Diaclone
- 12.5.1 Diaclone Company Information
- 12.5.2 Diaclone Business Overview
- 12.5.3 Diaclone Revenue in Phage Display Service Business (2021-2026)
- 12.5.4 Diaclone Phage Display Service Product Portfolio
- 12.5.5 Diaclone Recent Developments
- 12.6 Biomolecular Discovery Services
- 12.6.1 Biomolecular Discovery Services Company Information
- 12.6.2 Biomolecular Discovery Services Business Overview
- 12.6.3 Biomolecular Discovery Services Revenue in Phage Display Service Business (2021-2026)
- 12.6.4 Biomolecular Discovery Services Phage Display Service Product Portfolio
- 12.6.5 Biomolecular Discovery Services Recent Developments
- 12.7 Charles River
- 12.7.1 Charles River Company Information
- 12.7.2 Charles River Business Overview
- 12.7.3 Charles River Revenue in Phage Display Service Business (2021-2026)
- 12.7.4 Charles River Phage Display Service Product Portfolio
- 12.7.5 Charles River Recent Developments
- 12.8 GenScript
- 12.8.1 GenScript Company Information
- 12.8.2 GenScript Business Overview
- 12.8.3 GenScript Revenue in Phage Display Service Business (2021-2026)
- 12.8.4 GenScript Phage Display Service Product Portfolio
- 12.8.5 GenScript Recent Developments
- 12.9 Synbio Technologies
- 12.9.1 Synbio Technologies Company Information
- 12.9.2 Synbio Technologies Business Overview
- 12.9.3 Synbio Technologies Revenue in Phage Display Service Business (2021-2026)
- 12.9.4 Synbio Technologies Phage Display Service Product Portfolio
- 12.9.5 Synbio Technologies Recent Developments
- 12.10 Creative Peptides
- 12.10.1 Creative Peptides Company Information
- 12.10.2 Creative Peptides Business Overview
- 12.10.3 Creative Peptides Revenue in Phage Display Service Business (2021-2026)
- 12.10.4 Creative Peptides Phage Display Service Product Portfolio
- 12.10.5 Creative Peptides Recent Developments
- 12.11 ProImmune
- 12.11.1 ProImmune Company Information
- 12.11.2 ProImmune Business Overview
- 12.11.3 ProImmune Revenue in Phage Display Service Business (2021-2026)
- 12.11.4 ProImmune Phage Display Service Product Portfolio
- 12.11.5 ProImmune Recent Developments
- 12.12 Absolute Antibody
- 12.12.1 Absolute Antibody Company Information
- 12.12.2 Absolute Antibody Business Overview
- 12.12.3 Absolute Antibody Revenue in Phage Display Service Business (2021-2026)
- 12.12.4 Absolute Antibody Phage Display Service Product Portfolio
- 12.12.5 Absolute Antibody Recent Developments
- 12.13 Iontas
- 12.13.1 Iontas Company Information
- 12.13.2 Iontas Business Overview
- 12.13.3 Iontas Revenue in Phage Display Service Business (2021-2026)
- 12.13.4 Iontas Phage Display Service Product Portfolio
- 12.13.5 Iontas Recent Developments
- 12.14 LakePharma
- 12.14.1 LakePharma Company Information
- 12.14.2 LakePharma Business Overview
- 12.14.3 LakePharma Revenue in Phage Display Service Business (2021-2026)
- 12.14.4 LakePharma Phage Display Service Product Portfolio
- 12.14.5 LakePharma Recent Developments
- 12.15 KMD Bioscience
- 12.15.1 KMD Bioscience Company Information
- 12.15.2 KMD Bioscience Business Overview
- 12.15.3 KMD Bioscience Revenue in Phage Display Service Business (2021-2026)
- 12.15.4 KMD Bioscience Phage Display Service Product Portfolio
- 12.15.5 KMD Bioscience Recent Developments
- 12.16 NeoClone
- 12.16.1 NeoClone Company Information
- 12.16.2 NeoClone Business Overview
- 12.16.3 NeoClone Revenue in Phage Display Service Business (2021-2026)
- 12.16.4 NeoClone Phage Display Service Product Portfolio
- 12.16.5 NeoClone Recent Developments
- 12.17 Pepscan
- 12.17.1 Pepscan Company Information
- 12.17.2 Pepscan Business Overview
- 12.17.3 Pepscan Revenue in Phage Display Service Business (2021-2026)
- 12.17.4 Pepscan Phage Display Service Product Portfolio
- 12.17.5 Pepscan Recent Developments
- 12.18 Abzena
- 12.18.1 Abzena Company Information
- 12.18.2 Abzena Business Overview
- 12.18.3 Abzena Revenue in Phage Display Service Business (2021-2026)
- 12.18.4 Abzena Phage Display Service Product Portfolio
- 12.18.5 Abzena Recent Developments
- 12.19 ChemPartner
- 12.19.1 ChemPartner Company Information
- 12.19.2 ChemPartner Business Overview
- 12.19.3 ChemPartner Revenue in Phage Display Service Business (2021-2026)
- 12.19.4 ChemPartner Phage Display Service Product Portfolio
- 12.19.5 ChemPartner Recent Developments
- 12.20 Creative Proteomics
- 12.20.1 Creative Proteomics Company Information
- 12.20.2 Creative Proteomics Business Overview
- 12.20.3 Creative Proteomics Revenue in Phage Display Service Business (2021-2026)
- 12.20.4 Creative Proteomics Phage Display Service Product Portfolio
- 12.20.5 Creative Proteomics Recent Developments
- 12.21 Yntoab
- 12.21.1 Yntoab Company Information
- 12.21.2 Yntoab Business Overview
- 12.21.3 Yntoab Revenue in Phage Display Service Business (2021-2026)
- 12.21.4 Yntoab Phage Display Service Product Portfolio
- 12.21.5 Yntoab Recent Developments
- 12.22 Diane biological
- 12.22.1 Diane biological Company Information
- 12.22.2 Diane biological Business Overview
- 12.22.3 Diane biological Revenue in Phage Display Service Business (2021-2026)
- 12.22.4 Diane biological Phage Display Service Product Portfolio
- 12.22.5 Diane biological Recent Developments
- 12.23 Biosynth
- 12.23.1 Biosynth Company Information
- 12.23.2 Biosynth Business Overview
- 12.23.3 Biosynth Revenue in Phage Display Service Business (2021-2026)
- 12.23.4 Biosynth Phage Display Service Product Portfolio
- 12.23.5 Biosynth Recent Developments
- 12.24 Zoonbio Biotechnology
- 12.24.1 Zoonbio Biotechnology Company Information
- 12.24.2 Zoonbio Biotechnology Business Overview
- 12.24.3 Zoonbio Biotechnology Revenue in Phage Display Service Business (2021-2026)
- 12.24.4 Zoonbio Biotechnology Phage Display Service Product Portfolio
- 12.24.5 Zoonbio Biotechnology Recent Developments
- 12.25 Abiocenter
- 12.25.1 Abiocenter Company Information
- 12.25.2 Abiocenter Business Overview
- 12.25.3 Abiocenter Revenue in Phage Display Service Business (2021-2026)
- 12.25.4 Abiocenter Phage Display Service Product Portfolio
- 12.25.5 Abiocenter Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst